Pharma Faces: Demet Russ, Janssen Turkey
After an international career spanning 25 years, Demet Russ returned to her native Turkey to lead the Janssen affiliate during a tumultuous time and is aiming to give back to…
Address: Yenişehir Mah. Özgür Sokak 16, Ataşehir/ Istanbul,Turkey
Tel: 0216 456 65 70
Web: http://www.berkoilac.com.tr/default.aspx
BERKO PHARMACEUTICALS initiallystarted its operations under the name of BERAN LABORATORY in Diyarbakır.A few years later, in 1984, BERKO PHARMACEUTICALS was founded inIstanbul. BERKO PHARMACEUTICALS, which initially produced a galenicpreparation, soon started to manufacture therapeutic medicines in itsown production facility.
In the early 2000’s, BERKOPHARMACEUTICALS started licensing new pharmaceuticals needed in Turkey.Consequently, various forms of zinc-containing ZINCO-branded productswere offered for the benefit of Turkish Medicine. Around that time, anagency agreement was signed with the Italian GANASSINI company, andsubsequently the importation and distribution of the Ear-Nose-Throatspecific medicines, TONIMER line, were initiated.
BERKOPHARMACEUTICALS founded its own production facilities early in 2004,and has come to produce a wide product range of ground breakingmedicine, all of which, with the exceptions of a few imports, itproduces itself in its own modern production facilities. BERKOPHARMACEUTICALS continues to offer both new and existing high-demandedbrands to the pediatric market.
BERKO PHARMACEUTICALS’ new high-tech facility started production in 2009.
BERKOPHARMACEUTICALS’ new production facility in Sultanbeyli, Istanbul, isdesigned to produce licensed medicines under the supervision of theMinistry of Health, Republic of Turkey. The 5000 m2 indoor facility wasdesigned in accordance with all relevant GMP requirements. Both thebuilding and the inner equipment -machine park and laboratory- of thisfactory were constructed by the latest technology.
Our liquidmanufacturing capacity under normal working conditions is 6,500,000boxes per year for syrups; 6,500,000 boxes per year for drops; and8,000,000 boxes per year for solid medicines.
BERKO PHARMACEUTICALS aims to manufacture only products that will always be in demand, while continuing to break new grounds.
Aftasol solution
Berko-Fiz Nasal Drops
ACD3 drops
Alores Syrup
Caillou Fish
Dencol Gel Spray
FerroZinc Syrup
Folas Drop…
After an international career spanning 25 years, Demet Russ returned to her native Turkey to lead the Janssen affiliate during a tumultuous time and is aiming to give back to…
Avinash Potnis of Novartis Turkey discusses potential solutions to the country’s access and pricing dilemma which has raised concerns of system sustainability. Potnis also highlights the strengths of Turkey’s healthcare…
Ingrid Drechsel, head of Bayer’s pharma operations in Turkey and Iran, discusses the complexity of managing two countries under economic pressure and the advantages of Bayer’s longstanding relationship in both…
Menarini’s general manager for Turkey, the Middle East and Africa Uğur Bingöl discusses the Italian company’s restructuring in the region and its desire to replicate its success in Turkey across…
The secretary general for Turkey’s Pharmaceutical Manufacturers Association (IEIS), Savaş Malkoç, highlights their objective of increasing R&D expenditure and Turkey’s big opportunity ahead in biosimilars production. In addition, Malkoç discusses…
Janssen’s Managing Director for Turkey, Demet Russ, discusses her return to the country after 25 years abroad, having worked for Johnson & Johnson in different local, regional and global roles…
As one of the leading pharma companies in Turkey, DEVA is pioneering a new approach to generics in the country. Chairman of the Board and CEO Philipp Haas discusses the…
As COVID-19 began spreading through the world, the race to understand the disease by scientists and doctors took off. After just a few months, it became apparent that people with…
The president of the Turkish Society of Cardiology, Mustafa Kemal Erol, discusses the prevalence of cardiovascular disease, which accounts for over a third of deaths in Turkey, the improvements made…
AmCham Turkey’s executive director, Asli Özelli, examines the impact of US companies on the Turkish economy with over USD 50 billion in investment, their help during the pandemic, the chamber’s…
Dr Burak Cem, Novo Nordisk Vice President and General Manager for Turkey, outlines the company’s big bet on Turkey as a future regional hub through deep investment in clinical trials,…
Turkey’s former Minister of Health, Bülent Akarcali, outlines the country’s healthcare system evolution over the past decades, comparing the improvements to the difference between a Ford Model T to a…
See our Cookie Privacy Policy Here
